F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Metabolic associated fatty liver disease

Page 1 of 1 ( 24 items )
<<
1
>>

1	Prevalence of metabolic dysfunction-associated fatty liver disease among health check-up attendees: A retrospective study conducted in Vietnam 9/25/2025 3:33:10 AM \| Browse: 140 \| Download: 274
2	Fibrinogen superfamily proteins: Key regulators in hepatic disorders 8/12/2025 8:18:27 AM \| Browse: 55 \| Download: 321
3	Immune cells in metabolic associated fatty liver disease: Global trends and hotspots (2004-2024) 3/26/2025 4:06:55 AM \| Browse: 227 \| Download: 489
4	Association of Life’s Essential 8 and Life’s Simple 7 with metabolic-associated fatty liver disease in the United States 2/20/2025 8:40:19 AM \| Browse: 115 \| Download: 598
5	Quantitative assessment of self-management in patients with non-alcoholic fatty liver disease: An unmet clinical need 7/1/2024 7:39:37 AM \| Browse: 205 \| Download: 588
6	Manipulation of the intestinal microbiome-a slow journey to primetime 7/27/2023 1:26:07 AM \| Browse: 338 \| Download: 965
7	Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes 4/20/2023 7:26:29 AM \| Browse: 396 \| Download: 1071
8	Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate 2/24/2023 1:35:50 PM \| Browse: 506 \| Download: 1188
9	Prognostic performance of an index based on lactic dehydrogenase and transaminases for patients with liver steatosis and COVID-19 9/29/2022 10:42:42 AM \| Browse: 745 \| Download: 2615
10	Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future? 9/23/2022 12:48:56 AM \| Browse: 648 \| Download: 1349
11	Metabolic-associated fatty liver disease is associated with low muscle mass and strength in patients with chronic hepatitis B 8/26/2022 9:51:35 AM \| Browse: 477 \| Download: 1780
12	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 661 \| Download: 2003
13	Comments on validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease 2/9/2022 7:25:27 AM \| Browse: 647 \| Download: 1657
14	Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible? 1/21/2022 8:16:14 AM \| Browse: 680 \| Download: 1420
15	Gut dysbiosis and systemic inflammation promote cardiomyocyte abnormalities in an experimental model of steatohepatitis 12/27/2021 5:24:00 AM \| Browse: 691 \| Download: 2020
16	Probiotics in hepatology: An update 9/22/2021 8:09:41 AM \| Browse: 852 \| Download: 1968
17	Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease 9/9/2021 6:46:56 AM \| Browse: 676 \| Download: 1788
18	Clinical perspectives, assessment, and mechanisms of metabolic associated fatty liver disease in patients with COVID-19 9/3/2021 11:45:55 AM \| Browse: 812 \| Download: 1417
19	Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence 8/20/2021 9:33:19 AM \| Browse: 939 \| Download: 2075
20	Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease 8/10/2021 6:48:42 AM \| Browse: 739 \| Download: 1507
21	Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic associated fatty liver disease 4/9/2021 9:07:56 AM \| Browse: 877 \| Download: 2297
22	Clinic-pathological features of metabolic associated fatty liver disease with hepatitis B virus infection 1/25/2021 6:05:27 AM \| Browse: 615 \| Download: 2220
23	Metabolic associated fatty liver disease: Addressing a new era in liver transplantation 12/18/2020 5:58:43 AM \| Browse: 1000 \| Download: 1682
24	Macrophages in metabolic associated fatty liver disease 4/28/2020 8:04:30 AM \| Browse: 1123 \| Download: 1851

Page 1 of 1 ( 24 items )
<<
1
>>

1	Prevalence of metabolic dysfunction-associated fatty liver disease among health check-up attendees: A retrospective study conducted in Vietnam 9/25/2025 3:33:10 AM \| Browse: 140 \| Download: 274
2	Fibrinogen superfamily proteins: Key regulators in hepatic disorders 8/12/2025 8:18:27 AM \| Browse: 55 \| Download: 321
3	Immune cells in metabolic associated fatty liver disease: Global trends and hotspots (2004-2024) 3/26/2025 4:06:55 AM \| Browse: 227 \| Download: 489
4	Association of Life’s Essential 8 and Life’s Simple 7 with metabolic-associated fatty liver disease in the United States 2/20/2025 8:40:19 AM \| Browse: 115 \| Download: 598
5	Quantitative assessment of self-management in patients with non-alcoholic fatty liver disease: An unmet clinical need 7/1/2024 7:39:37 AM \| Browse: 205 \| Download: 588
6	Manipulation of the intestinal microbiome-a slow journey to primetime 7/27/2023 1:26:07 AM \| Browse: 338 \| Download: 965
7	Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes 4/20/2023 7:26:29 AM \| Browse: 396 \| Download: 1071
8	Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate 2/24/2023 1:35:50 PM \| Browse: 506 \| Download: 1188
9	Prognostic performance of an index based on lactic dehydrogenase and transaminases for patients with liver steatosis and COVID-19 9/29/2022 10:42:42 AM \| Browse: 745 \| Download: 2615
10	Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future? 9/23/2022 12:48:56 AM \| Browse: 648 \| Download: 1349
11	Metabolic-associated fatty liver disease is associated with low muscle mass and strength in patients with chronic hepatitis B 8/26/2022 9:51:35 AM \| Browse: 477 \| Download: 1780
12	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 661 \| Download: 2003
13	Comments on validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease 2/9/2022 7:25:27 AM \| Browse: 647 \| Download: 1657
14	Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible? 1/21/2022 8:16:14 AM \| Browse: 680 \| Download: 1420
15	Gut dysbiosis and systemic inflammation promote cardiomyocyte abnormalities in an experimental model of steatohepatitis 12/27/2021 5:24:00 AM \| Browse: 691 \| Download: 2020
16	Probiotics in hepatology: An update 9/22/2021 8:09:41 AM \| Browse: 852 \| Download: 1968
17	Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease 9/9/2021 6:46:56 AM \| Browse: 676 \| Download: 1788
18	Clinical perspectives, assessment, and mechanisms of metabolic associated fatty liver disease in patients with COVID-19 9/3/2021 11:45:55 AM \| Browse: 812 \| Download: 1417
19	Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence 8/20/2021 9:33:19 AM \| Browse: 939 \| Download: 2075
20	Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease 8/10/2021 6:48:42 AM \| Browse: 739 \| Download: 1507
21	Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic associated fatty liver disease 4/9/2021 9:07:56 AM \| Browse: 877 \| Download: 2297
22	Clinic-pathological features of metabolic associated fatty liver disease with hepatitis B virus infection 1/25/2021 6:05:27 AM \| Browse: 615 \| Download: 2220
23	Metabolic associated fatty liver disease: Addressing a new era in liver transplantation 12/18/2020 5:58:43 AM \| Browse: 1000 \| Download: 1682
24	Macrophages in metabolic associated fatty liver disease 4/28/2020 8:04:30 AM \| Browse: 1123 \| Download: 1851